Feedback / Questions
EGL-003 - Egle Therap
https://www.businesswire.com/news/home/20251202739016/en/Egle-Therapeutics-Initiates-Phase-1-Healthy-Volunteer-Study-of-EGL-003-a-Next-Generation-Treg-IL-2-Agonist-for-Atopic-Dermatitis
Dec 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next